Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parirenyatwa OMIDOSE Trial
PACTR202610664027536Phase 4Recruiting
- Sponsor
- Parirenyatwa Group of Hospitals
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of misoprostol (2 arms), sponsored by Parirenyatwa Group of Hospitals. Started Oct 2026; status: recruiting.
02
Drugs
misoprostol
Beyond the preview
Go deeper on PACTR202610664027536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610664027536.